tiprankstipranks
Amgen Inc (AMGN)
NASDAQ:AMGN
US Market
AMGN
Amgen
RESEARCH TOOLSreports
Want to see AMGN full AI Analyst Report?

Amgen (AMGN) Stock Forecast & Price Target

6,898 Followers
See the Price Targets and Ratings of:

AMGN Analyst Ratings

Moderate Buy
24Ratings
Moderate Buy
10 Buy
13 Hold
1 Sell
Based on 24 analysts giving stock ratings to
Amgen
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AMGN Stock 12 Month Forecast

Average Price Target

$361.33
▲(1.70% Upside)
Based on 24 Wall Street analysts offering 12 month price targets for Amgen in the last 3 months. The average price target is $361.33 with a high forecast of $427.00 and a low forecast of $300.00. The average price target represents a 1.70% change from the last price of $355.30.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"279":"$279","428":"$428","316.25":"$316.3","353.5":"$353.5","390.75":"$390.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":427,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$427.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":361.33210526315787,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$361.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":300,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$300.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[279,316.25,353.5,390.75,428],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,329.13,336.65846153846155,344.18692307692305,351.7153846153846,359.24384615384616,366.77230769230766,374.3007692307692,381.8292307692308,389.35769230769233,396.88615384615383,404.4146153846154,411.9430769230769,419.47153846153844,{"y":427,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,329.13,331.6070850202429,334.08417004048584,336.56125506072874,339.03834008097164,341.5154251012146,343.9925101214575,346.4695951417004,348.9466801619433,351.42376518218623,353.9008502024291,356.377935222672,358.855020242915,{"y":361.33210526315787,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,329.13,326.8892307692308,324.64846153846156,322.4076923076923,320.16692307692307,317.92615384615385,315.68538461538463,313.44461538461536,311.20384615384614,308.9630769230769,306.7223076923077,304.48153846153843,302.2407692307692,{"y":300,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":280.052,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":282.042,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":288.216,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":281.58,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":292.14,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":292.071,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":332.655,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":322.621,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":339.742,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":382.809,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":350.632,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":327.348,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":329.13,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$427.00Average Price Target$361.33Lowest Price Target$300.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on AMGN
Courtney Breen
Bernstein
Bernstein
―
Hold
―
Reiterated
06/01/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN) and Thermo Fisher (NYSE: TMO)
Piper Sandler Analyst forecast on AMGN
David Amsellem
Piper Sandler
Piper Sandler
$427
Buy
20.18%
Upside
Reiterated
05/29/26
Analysts Offer Insights on Healthcare Companies: Immatics (NASDAQ: IMTX) and Amgen (NASDAQ: AMGN)
TD Cowen Analyst forecast on AMGN
Yaron Werber
TD Cowen
TD Cowen
$420→$326.31
Buy
-8.16%
Downside
Reiterated
05/18/26
Amgen (AMGN, Buy, $326.31, Werber): Dazodalibep (anti-CD40L, IV Q2W-Q4W) stands out as a potentially differentiated SjD entrant by pursuing both systemic and importantly, the larger symptomatic population, where few programs have shown meaningful patient-reported benefit.
Freedom Capital Markets Analyst forecast on AMGN
Ilya Zubkov
Freedom Capital Markets
Freedom Capital Markets
$375
Buy
5.54%
Upside
Upgraded
05/07/26
Amgen upgraded to Buy from Hold at Freedom BrokerAmgen upgraded to Buy from Hold at Freedom Broker
Erste Group Analyst forecast on AMGN
Hans Engel
Erste Group
Erste Group
―
Hold
―
Downgraded
05/05/26
Amgen downgraded to Hold from Buy at Erste GroupAmgen downgraded to Hold from Buy at Erste Group
Barclays Analyst forecast on AMGN
Emily Field
Barclays
Barclays
$350
Hold
-1.49%
Downside
Reiterated
05/05/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Xencor (NASDAQ: XNCR), Inspire Medical Systems (NYSE: INSP) and Amgen (NASDAQ: AMGN)
BMO Capital Analyst forecast on AMGN
Evan Seigerman
BMO Capital
BMO Capital
$400
Buy
12.58%
Upside
Reiterated
05/04/26
Amgen (AMGN) Gets a Buy from BMO Capital
Guggenheim Analyst forecast on AMGN
Vamil Divan
Guggenheim
Guggenheim
$351→$340
Hold
-4.31%
Downside
Reiterated
05/03/26
Guggenheim Sticks to Their Hold Rating for Amgen (AMGN)
Raymond James Analyst forecast on AMGN
Unknown Analyst
Raymond James
Not Ranked
Raymond James
―
Hold
―
Assigned
05/01/26
Raymond James Issues a Hold Rating on Amgen (AMGN)
J.P. Morgan Analyst forecast on AMGN
Unknown Analyst
J.P. Morgan
Not Ranked
J.P. Morgan
$300
Hold
-15.56%
Downside
Initiated
05/01/26
Amgen (AMGN) Gets a Hold from J.P. Morgan
Truist Financial Analyst forecast on AMGN
Gregory Renza
Truist Financial
Truist Financial
$325→$327
Hold
-7.97%
Downside
Reiterated
05/01/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), Weave Communications (NYSE: WEAV) and OrthoPediatrics (NASDAQ: KIDS)
Morgan Stanley Analyst forecast on AMGN
Terence Flynn
Morgan Stanley
Morgan Stanley
$326→$332
Hold
-6.56%
Downside
Assigned
05/01/26
Morgan Stanley Keeps Their Hold Rating on Amgen (AMGN)
Citi Analyst forecast on AMGN
Geoff Meacham
Citi
Citi
$345
Hold
-2.90%
Downside
Reiterated
05/01/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), Phathom Pharmaceuticals (NASDAQ: PHAT) and Zimmer Biomet Holdings (NYSE: ZBH)
Goldman Sachs Analyst forecast on AMGN
Salveen Richter
Goldman Sachs
Goldman Sachs
$415→$425
Buy
19.62%
Upside
Assigned
05/01/26
Amgen Price Target Raised to $425 as Strong Execution and Expanding Pipeline Underpin Maintained Buy Rating
Evercore ISI Analyst forecast on AMGN
Umer Raffat
Evercore ISI
Evercore ISI
―
Buy
―
Reiterated
05/01/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Amgen (NASDAQ: AMGN), Alnylam Pharma (NASDAQ: ALNY) and The Ensign Group (NASDAQ: ENSG)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on AMGN
Courtney Breen
Bernstein
Bernstein
―
Hold
―
Reiterated
06/01/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN) and Thermo Fisher (NYSE: TMO)
Piper Sandler Analyst forecast on AMGN
David Amsellem
Piper Sandler
Piper Sandler
$427
Buy
20.18%
Upside
Reiterated
05/29/26
Analysts Offer Insights on Healthcare Companies: Immatics (NASDAQ: IMTX) and Amgen (NASDAQ: AMGN)
TD Cowen Analyst forecast on AMGN
Yaron Werber
TD Cowen
TD Cowen
$420→$326.31
Buy
-8.16%
Downside
Reiterated
05/18/26
Amgen (AMGN, Buy, $326.31, Werber): Dazodalibep (anti-CD40L, IV Q2W-Q4W) stands out as a potentially differentiated SjD entrant by pursuing both systemic and importantly, the larger symptomatic population, where few programs have shown meaningful patient-reported benefit.
Freedom Capital Markets Analyst forecast on AMGN
Ilya Zubkov
Freedom Capital Markets
Freedom Capital Markets
$375
Buy
5.54%
Upside
Upgraded
05/07/26
Amgen upgraded to Buy from Hold at Freedom BrokerAmgen upgraded to Buy from Hold at Freedom Broker
Erste Group Analyst forecast on AMGN
Hans Engel
Erste Group
Erste Group
―
Hold
―
Downgraded
05/05/26
Amgen downgraded to Hold from Buy at Erste GroupAmgen downgraded to Hold from Buy at Erste Group
Barclays Analyst forecast on AMGN
Emily Field
Barclays
Barclays
$350
Hold
-1.49%
Downside
Reiterated
05/05/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Xencor (NASDAQ: XNCR), Inspire Medical Systems (NYSE: INSP) and Amgen (NASDAQ: AMGN)
BMO Capital Analyst forecast on AMGN
Evan Seigerman
BMO Capital
BMO Capital
$400
Buy
12.58%
Upside
Reiterated
05/04/26
Amgen (AMGN) Gets a Buy from BMO Capital
Guggenheim Analyst forecast on AMGN
Vamil Divan
Guggenheim
Guggenheim
$351→$340
Hold
-4.31%
Downside
Reiterated
05/03/26
Guggenheim Sticks to Their Hold Rating for Amgen (AMGN)
Raymond James Analyst forecast on AMGN
Unknown Analyst
Raymond James
Not Ranked
Raymond James
―
Hold
―
Assigned
05/01/26
Raymond James Issues a Hold Rating on Amgen (AMGN)
J.P. Morgan Analyst forecast on AMGN
Unknown Analyst
J.P. Morgan
Not Ranked
J.P. Morgan
$300
Hold
-15.56%
Downside
Initiated
05/01/26
Amgen (AMGN) Gets a Hold from J.P. Morgan
Truist Financial Analyst forecast on AMGN
Gregory Renza
Truist Financial
Truist Financial
$325→$327
Hold
-7.97%
Downside
Reiterated
05/01/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), Weave Communications (NYSE: WEAV) and OrthoPediatrics (NASDAQ: KIDS)
Morgan Stanley Analyst forecast on AMGN
Terence Flynn
Morgan Stanley
Morgan Stanley
$326→$332
Hold
-6.56%
Downside
Assigned
05/01/26
Morgan Stanley Keeps Their Hold Rating on Amgen (AMGN)
Citi Analyst forecast on AMGN
Geoff Meacham
Citi
Citi
$345
Hold
-2.90%
Downside
Reiterated
05/01/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), Phathom Pharmaceuticals (NASDAQ: PHAT) and Zimmer Biomet Holdings (NYSE: ZBH)
Goldman Sachs Analyst forecast on AMGN
Salveen Richter
Goldman Sachs
Goldman Sachs
$415→$425
Buy
19.62%
Upside
Assigned
05/01/26
Amgen Price Target Raised to $425 as Strong Execution and Expanding Pipeline Underpin Maintained Buy Rating
Evercore ISI Analyst forecast on AMGN
Umer Raffat
Evercore ISI
Evercore ISI
―
Buy
―
Reiterated
05/01/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Amgen (NASDAQ: AMGN), Alnylam Pharma (NASDAQ: ALNY) and The Ensign Group (NASDAQ: ENSG)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Amgen

3 Months
David AmsellemPiper Sandler
Success Rate
11/17 ratings generated profit
65%
Average Return
+4.67%
Copying David Amsellem's trades and holding each position for 3 Months would result in 64.71% of your transactions generating a profit, with an average return of +4.67% per trade.
1 Year
David AmsellemPiper Sandler
Success Rate
14/17 ratings generated profit
82%
Average Return
+13.33%
Copying David Amsellem's trades and holding each position for 1 Year would result in 82.35% of your transactions generating a profit, with an average return of +13.33% per trade.
2 Years
Michael YeeUBS
Success Rate
48/53 ratings generated profit
91%
Average Return
+21.55%
Copying Michael Yee's trades and holding each position for 2 Years would result in 90.57% of your transactions generating a profit, with an average return of +21.55% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AMGN Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
32
27
25
25
21
Hold
18
20
25
27
23
Sell
2
2
1
2
2
Strong Sell
0
0
0
0
0
total
52
49
51
54
46
In the current month, AMGN has received 21 Buy Ratings, 23 Hold Ratings, and 2 Sell Ratings. AMGN average Analyst price target in the past 3 months is 361.33.
Each month's total comprises the sum of three months' worth of ratings.

AMGN Financial Forecast

AMGN Earnings Forecast

Next quarter’s earnings estimate for AMGN is $5.59 with a range of $4.99 to $6.28. The previous quarter’s EPS was $5.15. AMGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year AMGN has Performed in-line its overall industry.
Next quarter’s earnings estimate for AMGN is $5.59 with a range of $4.99 to $6.28. The previous quarter’s EPS was $5.15. AMGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year AMGN has Performed in-line its overall industry.

AMGN Sales Forecast

Next quarter’s sales forecast for AMGN is $9.43B with a range of $9.21B to $9.63B. The previous quarter’s sales results were $8.65B. AMGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year AMGN has Performed in-line its overall industry.
Next quarter’s sales forecast for AMGN is $9.43B with a range of $9.21B to $9.63B. The previous quarter’s sales results were $8.65B. AMGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year AMGN has Performed in-line its overall industry.

AMGN Stock Forecast FAQ

What is AMGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Amgen Inc’s 12-month average price target is 361.33.
    What is AMGN’s upside potential, based on the analysts’ average price target?
    Amgen Inc has 1.70% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is AMGN a Buy, Sell or Hold?
          Amgen Inc has a consensus rating of Moderate Buy which is based on 10 buy ratings, 13 hold ratings and 1 sell ratings.
            What is Amgen Inc’s price target?
            The average price target for Amgen Inc is 361.33. This is based on 24 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $427.00 ,the lowest forecast is $300.00. The average price target represents 1.70% Increase from the current price of $355.3.
              What do analysts say about Amgen Inc?
              Amgen Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 24 Wall Streets Analysts.
                How can I buy shares of AMGN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.